Status:

UNKNOWN

Trajectory Analysis of Symptom Distress and Cancer-related Fatigue After Adjuvant Chemotherapy in Breast Cancer Female

Lead Sponsor:

Taipei Medical University

Conditions:

Symptom Distress During Breast Cancer Treatment

Eligibility:

FEMALE

20+ years

Brief Summary

When receiving adjuvant chemotherapy, a variety of symptoms will appear and it is very painful. These symptoms occur at the same time and are related to each other. The symptom distress may affect the...

Eligibility Criteria

Inclusion

  • The surgical pathological tissue report confirms that the diagnosis is zero stage breast carcinoma in situ women and stage I\~III Breast cancer women.
  • Those who are admitted to the hospital for the first time adjuvant chemotherapy or hormonal therapy.
  • Age (inclusive) over 20 years old

Exclusion

  • Women with breast cancer who are unconscious or unable to express.

Key Trial Info

Start Date :

May 29 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 31 2024

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04911699

Start Date

May 29 2021

End Date

July 31 2024

Last Update

June 3 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.